Sequential evaluation of clinical and laboratory changes amongst children suffering from lupus nephritis during intermittent intravenous cyclophosphamide therapy

By Chiu Shih-Jung   Ou Liang-Shiou   Tsai Tien-Lung   Hung Iou-Jih   Huang Jing-Long  

Clinical Rheumatology, Vol. 25, Iss. 4, 2006-07 ,pp. : 515-519

Springer Publishing Company

Access to resources Recommend Favorite

Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy

By Kuroda Takeshi   Hirose Shintaro   Tanabe Naohito   Sato Hiroe   Nakatsue Takeshi   Ajiro Jyunya   Wada Yoko   Murakami Syuichi   Hasegawa Hisashi   Ito Satoshi   Sakatsume Minoru   Nakano Masaaki   Gejyo Fumitake  

Modern Rheumatology, Vol. 17, Iss. 3, 2007-06 ,pp. : 206-212

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis

By Takahashi Satoshi  

Modern Rheumatology, Vol. 21, Iss. 3, 2011-06 ,pp. : 282-289

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of clinical manifestations and pathology of lupus nephritis: a retrospective review of 82 cases

By Guo Qiaoyan   Lu Xuehong   Miao Lining   Wu Man   Lu Shan   Luo Ping  

Clinical Rheumatology, Vol. 29, Iss. 10, 2010-10 ,pp. : 1175-1180

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Features of Antibody-Induced Complete Secondary Failure of Botulinum Toxin Therapy

By  

European Neurology, Vol. 48, Iss. 1, 2002-07 ,pp. : 26-29

Karger

Access to resources Recommend Favorite